| Term 
 
        | Hydroxychloroquine Use
 Mechanism
 Adverse Effects
 Contra
 Special
 |  | Definition 
 
        | Mild RA/SLE Alkalinize Lysosome/Vesicle
 Impairs Ag processing/cytokine prod.
 GI upset
 skin rxns (mild)
 AGEP-Acute Gen. Exanthematous Pustulosis
 Retinopathy
 Pre-existing ocular disease
 Min effect on done destruction-weak drug
 |  | 
        |  | 
        
        | Term 
 
        | Leflunomide Use
 Mechanism
 Adverse Effects
 Contra
 Special
 |  | Definition 
 
        | RA Prodrug->M1
 Inhibit de novo pyrimadine synth.
 Arrest in G1
 GI
 Myelosuppression
 Alopecia
 Hepatotoxicity
 Teratogenesis
 Pregnancy/breastfeeding
 Hepatic disease
 CYP inhibitor
 Fast acting (4 wks)
 long t1/2 (2 years until cleared)
 |  | 
        |  | 
        
        | Term 
 
        | TNF-alpha inhibitors Use
 Mechanism
 Adverse Effects
 Interactions
 Special
 |  | Definition 
 
        | RA Autoimmun/inflamm disease
 Block TNF-alpha from getting to receptor
 Infection risk
 Hypersensitivity
 autoantibody formation
 malignancy
 cytopenia
 neurologic disorders
 Not w/anakinra or abatacept
 Dont combine 2 TNF-a inhib.
 Fast onset 1 day
 MTX synergism
 |  | 
        |  | 
        
        | Term 
 
        | Anakinra Use
 Mechanism
 Adverse Effects
 Interactions
 Special
 |  | Definition 
 
        | RA IL-1R antagonist
 Immunosuppression
 Dont combo w/ TNF-a inhib.
 Ineffective alone-use in combo
 |  | 
        |  | 
        
        | Term 
 
        | Abatacept Use
 Mechanism
 Adverse Effects
 Interactions
 Special
 |  | Definition 
 
        | RA CTLA4+IgG
 stops costim signal of B7 from APC to T cell
 Immunosuppression
 Worsen COPD
 Dont combo w/ TNF-a inhib.
 Ineffective alone-use in combo
 |  | 
        |  | 
        
        | Term 
 
        | Rituximab Use
 Mechanism
 Adverse Effects
 Contra
 Special
 |  | Definition 
 
        | B cell lymphomas leukemias
 RA (w/ MTX)
 mouse/human IgG to CD20
 inhib B cell activation
 B cell depletion for 6-9 months
 Cytopenia
 Infection risk up
 Mucocutaneous rxns
 Cardiac dysfunction
 Hypersensitivity
 additive hypotension
 |  | 
        |  | 
        
        | Term 
 
        | Sulfasalazine Use
 Mechanism
 Adverse Effects
 |  | Definition 
 
        | IBD RA
 AICAR build up
 Metabolites
 1. Antibacterial
 2. Inhib. prostaglandin and LTriene synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TNF-alpha inhibitor Human IgG to TNF-a
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TNF-alpha inhibitor Human IgG + TNF receptor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | TNF-alpha inhibitor Human monoclonal Ab to TNF-a
 |  | 
        |  | 
        
        | Term 
 
        | Certolizumab Class
 Structure
 |  | Definition 
 
        | TNF-alpha inhibitor Fab of Human Ab to TNF-a
 |  | 
        |  | 
        
        | Term 
 
        | Infliximab Class
 Structure
 Adverse Effects
 |  | Definition 
 
        | TNF-alpha inhibitor Human-mouse Ab to TNF-a
 Worse side effects
 Infusion rxn
 Hepatic failure
 |  | 
        |  |